The timescale is an aspiration attributed to Amodei, not a measured outcome of the adoption.
Machine-checked against the newsletter text; linked-source claims have not been independently verified.
Development
Novo Nordisk adopts Claude Science, with Dario Amodei describing the ambition of accelerating a century of biomedical progress into a decade.
Reporting date: (not necessarily the event date)
Attribution and reporting linked by this record; links do not imply independent verification.
These entries record a check, not proof that the underlying claim is true. Unless described in the article below, the scope of the check is unknown.
The timescale is an aspiration attributed to Amodei, not a measured outcome of the adoption.
Machine-checked against the newsletter text; linked-source claims have not been independently verified.
Suggest a correction — opens a GitHub draft for you to review and submit.